Post-transplantation Malignancy After Kidney Transplantation in Turkey

Area of Science:

• Nephrology
• Oncology
• Transplant Surgery

Background:

• Kidney transplantation is the optimal treatment for end-stage renal disease.
• Post-transplant malignancy is a concern, potentially linked to immunosuppression and oncogenic infections.

Purpose of the Study:

• To determine the incidence of post-transplantation malignancy in kidney transplant recipients.
• To investigate the types and timing of malignancies after kidney transplant surgery.

Main Methods:

• Retrospective analysis of 2100 kidney transplant patients from May 2008 to December 2012.
• Inclusion of an additional 1900 patients transplanted by the same team in other centers.
• Evaluation of malignancy type, development time, immunosuppressive regimens, and viral status (Epstein-Barr virus, cytomegalovirus).

Main Results:

• Malignancy developed in 30 patients (1.4% of the total cohort).
• Median age of affected patients was 52.1 years, with 60% being male.
• Most common malignancies included non-melanoma skin cancer (40%), urogenital cancer (24%), and breast cancer (14%).

Conclusions:

• No increased post-transplantation malignancy risk was observed in this patient cohort.
• The use of low-dose immunosuppressive protocols may contribute to the observed lack of increased risk.
• Further research into immunosuppression strategies is warranted to mitigate malignancy risks.